A series of hybrids between primary human cells and a Chinese hamster somatic cell mutant (Mev-1), defective in expression of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase [(S)-3-hydroxy-3-methylglutaryl-CoA acetoacetyl-CoA-lyase (CoA-acetylating, EC 4.1.3.5], has been prepared that complements the mutant defect. A technique based on differential sensitivity of this enzyme activity to inhibition by magnesium ion is described that allows the discrimination of expression of human and hamster HMG-CoA synthase in these hybrids. The results indicate a structural gene defect in expression of HMG-CoA synthase activity in Mev-1 cells. Segregation of human chromosomes that do not possess the complementing marker have allowed the assignment of human HMG-CoA synthase activity to chromosome 5. This is the second demonstrably transcriptionally regulated enzyme of cholesterologenesis to be assigned to chromosome 5, the other being HMG-CoA reductase.
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Mevalonic acid is a key intermediate in the biosynthesis of several mammalian cellular products, including ubiquinone, dolichol, and cholesterol (1) . It also acts as a precursor for metabolic products that can modify functional groups on certain transfer RNAs (2) and polypeptides (3) . It appears that all of the enzymes of mevalonate biosynthesis undergo regulation by a number of these products but most strikingly by various regulatory sterols (4) . Interestingly, in somatic cell mutants of the Chinese hamster ovary CHO-K1 cell, these enzymes [acetoacetyl-coenzyme A thiolase (EC 2.3.1.9), 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase [(S)-3-hydroxy-3-methylglutaryl-CoA acetoacetylCoA-lyase(CoA-acetylating), EC 4.1.3.5], and HMG-CoA reductase (EC 1.1.1.88)] are all defectively regulated by sterols in the culture medium to about the same extent (5, 6) . With the recent finding that sterols regulate HMG-CoA reductase, at least in part, by a transcriptional control mechanism (7, 8) and that HMG-CoA synthase is likewise transcriptionally regulated (8) , the possibility arises that the organization of the genes encoding these enzymes on mammalian chromosomes could be of significance in understanding their control. Particular interest in the localization of these enzymes on human chromosomes also derives from the possible role of defective regulation of these enzymes in serum cholesterol levels and, hence, in the development of atherosclerosis (9) . The availability of well-defined cDNA probes for HMG-CoA reductase has allowed several laboratories to report recently the assignment of the gene encoding this enzyme to human chromosome 5 (20) (21) (22) .
Several years ago, we reported the isolation of a somatic cell mutant that is devoid of detectable HMG-CoA synthase activity (10) 
MATERIALS AND METHODS
Preparation of Human-Chinese Hamster Cell Hybrids. Fusions between the Mev-1 mutant cells and human peripheral blood lymphocytes or primary fibroblasts were performed by using polyethylene glycol as described (11) . Hybrid clones were isolated after growth in F-12 medium supplemented with 5% fetal calf serum. The isolation and characterization of hybrids made with Chinese hamster cells have been described (11, 12) .
Cytogenetic Analysis. Cytogenetic analysis was by sequential staining of chromosome preparations with trypsin-banding and Giemsa 11 differential staining procedures (13) .
Isozyme Analysis. Isozyme analysis for hexosaminidase B, which has been assigned to human chromosome 5, was performed on starch gel as described by Lalley et al. (14) . Other isozyme analyses were performed on Cellogel as described (11) .
HMG-CoA Synthase Assay. Assays were as described (10) with minor modifications. Cells for assay (2 x 106 per 150-mm dish) were incubated overnight in growth medium, after which the medium was switched to F-12 medium supplemented with 5% organic solvent-delipidized fetal calf serum (15) . After 48 hr, the cells were harvested by scraping with a rubber policeman into 0.2 ml of phosphate buffered saline (16) containing 0.1 ,M pepstatin, 1 mM phenylmethylsulfonyl fluoride, and 1 mM EDTA. These suspensions were sonicated in three 3-sec bursts and then centrifuged at 8000 rpm for 20 min. The supernatant was centrifuged at 40,000 rpm for 1 hr at 4°C and dialyzed 24 hr at 4°C against 20 mM KH2PO4, pH 7.2/0.1 mM EDTA/0.5 mM dithiothreitol/0.1 ,uM pepstatin. These extracts were stored at -200C. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (Fig. 1) . This assignment based on banding pattern is consistent with the isozyme data shown in Table 1 for the single chromosome hybrids. Since it is not necessarily the case that the loss of a particular cellular enzyme activity is due to a mutation in the structural gene for that enzyme, we also attempted to ascertain that the various hybrids that show complementation of the defect in Mev-1 express human HMG-CoA synthase activity. To do this, we developed a method based on a differential sensitivity of human and hamster HMG-CoA synthase activities to inhibition by magnesium ion. Titration ofhuman cell extracts and CHO-K1 cell extracts with various amounts of magnesium ion revealed a markedly different response (Fig. 2) possessed only human chromosome 5 isolated as described above (Table 2) . 
DISCUSSION
The data presented in this report clearly demonstrate the presence of a human gene encoding HMG-CoA synthase activity on chromosome 5. This result is of interest because of the possible transcriptional control by sterols of several enzymes in the cholesterol biosynthetic pathway, including HMG-CoA reductase, and the prior reports also assigning the human gene encoding that enzyme to chromosome 5. Other enzymes of cholesterol biosynthesis in cultured fibroblasts or liver that have been reported to be regulated by sterols (18) and mevalonate kinase (18) are defectively regulated in somatic cell mutants defective in the regulation of cholesterol biosynthesis by exogenous sterols. It is intriguing to speculate that the genes encoding these enzymes might exist in specialized regions of human chromatin that can facilitate their transcriptional control. Because of this possibility, and because of the possible role of defectively regulated enzymes in cholesterol biosynthesis in setting serum cholesterol levels, it has become of interest to assign these genes to the human chromosome map and to determine to as high a resolution as possible their precise location on those human chromosomes. The single chromosome hybrids bearing chromosome 5 that we have described in this report will probably be useful in this regard.
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